CONMED Beats Q3 2026 Earnings Forecast, Boosts Revenue Outlook With Strong Growth Plans
CONMED’s Q3 2026 earnings beat expectations, with Non‑GAAP EPS at $1.04, while a slight revenue shortfall is offset by stronger Q4 guidance and new product launches in orthopedic and surgical tools.
2 minutes to read